Decreased serum levels of the inflammaging marker miR-146a are associated with clinical non-response to tocilizumab in COVID-19 patients

Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China

(2020) Qiurong Ruan et al.   INTENSIVE CARE MEDICINE

Small extracellular vesicles deliver miR-21 and miR-217 as pro-senescence effectors to endothelial cells

(2020) Emanuela Mensà et al.   Journal of Extracellular Vesicles

Altered microRNA expression links IL6 and TNF-induced inflammaging with myeloid malignancy

(2020) Jennifer Margaret Grants et al.   BLOOD

Inflamm-aging: Why older men are the most susceptible to SARS-CoV-2 complicated outcomes

(2020) Massimiliano Bonafè et al.   CYTOKINE & GROWTH FACTOR REVIEWS

CT image visual quantitative evaluation and clinical classification of coronavirus disease (COVID-19)

(2020) Kunwei Li et al.   EUROPEAN RADIOLOGY

Tocilizumab treatment in COVID-19: A single center experience

(2020) Pan Luo et al.   JOURNAL OF MEDICAL VIROLOGY

Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial

(2020) Ivan Fan-Ngai Hung et al.   LANCET

COVID-19 and Italy: what next?

(2020) Andrea Remuzzi et al.   LANCET

Endothelial cell infection and endotheliitis in COVID-19

(2020) Zsuzsanna Varga et al.   LANCET

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

(2020) Fei Zhou et al.   LANCET

Effective treatment of severe COVID-19 patients with tocilizumab

(2020) Xiaoling Xu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

MiR-146a Ameliorates Hemoglobin-Induced Microglial Inflammatory Response via TLR4/IRAK1/TRAF6 Associated Pathways

(2020) Guang-Jie Liu et al.   Frontiers in Neuroscience

Endothelial HSPA12B Exerts Protection Against Sepsis-Induced Severe Cardiomyopathy via Suppression of Adhesion Molecule Expression by miR-126

(2020) Xia Zhang et al.   Frontiers in Immunology

Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study

(2020) Sofia Ramiro et al.   ANNALS OF THE RHEUMATIC DISEASES

Potential Role of Anti-interleukin (IL)-6 Drugs in the Treatment of COVID-19: Rationale, Clinical Evidence and Risks

(2020) Salvatore Crisafulli et al.   BIODRUGS

Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?

(2020) Bingwen Liu et al.   JOURNAL OF AUTOIMMUNITY

A Comprehensive Review of Tocilizumab in COVID‐19 Acute Respiratory Distress Syndrome

(2020) Sajad Khiali et al.   JOURNAL OF CLINICAL PHARMACOLOGY

A single-cell atlas of the peripheral immune response in patients with severe COVID-19

(2020) Aaron J. Wilk et al.   NATURE MEDICINE

Inflammation and thrombosis in COVID-19 pathophysiology: proteinase-activated and purinergic receptors as drivers and candidate therapeutic targets

(2020) Krishna Sriram et al.   PHYSIOLOGICAL REVIEWS

Circulating miR-146a in healthy aging and type 2 diabetes: Age- and gender-specific trajectories

(2019) Emanuela Mensà et al.   MECHANISMS OF AGEING AND DEVELOPMENT

Myeloid cell–targeted miR-146a mimic inhibits NF-κB–driven inflammation and leukemia progression in vivo

(2019) Yu-Lin Su et al.   BLOOD

Endothelial microRNAs regulating the NF-κB pathway and cell adhesion molecules during inflammation

(2018) Liang Zhong et al.   FASEB JOURNAL

Analysis of Plasma MicroRNAs as Predictors and Biomarkers of Aging and Frailty in Humans

(2018) Iryna Rusanova et al.   Oxidative Medicine and Cellular Longevity

Hall of Fame among Pro-inflammatory Cytokines: Interleukin-6 Gene and Its Transcriptional Regulation Mechanisms

(2016) Yang Luo et al.   Frontiers in Immunology

miR-146a-mediated suppression of the inflammatory response in human adipocytes

(2016) Julian Roos et al.   Scientific Reports

miR-146a-5p Antagonized AGEs- and P.g-LPS-Induced ABCA1 and ABCG1 Dysregulation in Macrophages via IRAK-1 Downregulation

(2015) Xia Li et al.   INFLAMMATION

Absolute quantification of cell-free microRNAs in cancer patients

(2015) Manuela Ferracin et al.   Oncotarget

Turning 21: Induction of miR-21 as a Key Switch in the Inflammatory Response

(2015) Frederick J. Sheedy   Frontiers in Immunology

Circulating inflamma-miRs in aging and age-related diseases

(2013) Fabiola Olivieri et al.   Frontiers in Genetics

MiR-146a as marker of senescence-associated pro-inflammatory status in cells involved in vascular remodelling

(2012) Fabiola Olivieri et al.   AGE

microRNAs in cancer management

(2012) Yi W Kong et al.   LANCET ONCOLOGY

Age-related differences in the expression of circulating microRNAs: miR-21 as a new circulating marker of inflammaging

(2012) Fabiola Olivieri et al.   MECHANISMS OF AGEING AND DEVELOPMENT

Up-Regulation of microRNA-126 May Contribute to Pathogenesis of Ulcerative Colitis via Regulating NF-kappaB Inhibitor IκBα

(2012) Xiao Feng et al.   PLoS One

Remodelling of biological parameters during human ageing: evidence for complex regulation in longevity and in type 2 diabetes

(2011) Liana Spazzafumo et al.   AGE

miR-146ais a significant brake on autoimmunity, myeloproliferation, and cancer in mice

(2011) Mark P. Boldin et al.   JOURNAL OF EXPERIMENTAL MEDICINE